RA PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
RA PHARMACEUTICALS, INC. reported Proceeds from Common Stock Issued of $140.53 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2019 was $140.53M, a 27.94% decline from fiscal 2018.
- RA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2018 was $195.01M.
| Period end | Proceeds from Issuance of Common Stock 12 month |
|---|---|
| 2019-12-31 | $140.53M 10-K · filed 2020-02-27 |
| 2018-12-31 | $195.01M 10-K · filed 2020-02-27 |